Merz Therapeutics and Kvvit sign exclusive agreement for INBRIJA in Greater China
Lundbeck's Vyepti (eptinezumab) receives South Korean approval for preventive treatment of migraine
Eli Lilly reports positive Phase 1b results for VERVE-102
Dicot Pharma submits FDA application for LIB-01 phase 2b study
European Commission approves Pharming's Joenja for APDS treatment in the EU
Caliway Biopharmaceuticals receives US FDA IND clearance for second global Phase 3 study of CBL-514
AbbVie's MAVIRET receives positive opinion from European regulator
Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
Upsher-Smith launches generic Cyclosporine Ophthalmic Emulsion 0.05%
Medtronic plans to SPR Therapeutics for USD650m to expand pain management portfolio
Implantica submits final FDA response for RefluxStop PMA application